ISHARES TR - U.S. PHARMA ETF (IHE)

CUSIP: 464288836

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / U.S. PHARMA ETF
Total 13F shares
494,862
Share change
-12,717
Total reported value
$87,906,779
Price per share
$177.66
Number of holders
99
Value change
-$2,280,688
Number of buys
27
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 464288836?
CUSIP 464288836 identifies IHE - ISHARES TR - U.S. PHARMA ETF in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IHE - ISHARES TR - U.S. PHARMA ETF (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q1 2021

As of 31 Mar 2021, ISHARES TR - U.S. PHARMA ETF (IHE) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 494,862 shares. The largest 10 holders included WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, MORGAN STANLEY, BROWN ADVISORY INC, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MURPHY CAPITAL MANAGEMENT INC, and Steward Partners Investment Advisory, LLC. This page lists 99 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
98
Q1 2021 holders
99
Holder diff
1
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .